Bioequivalence Study of Torrent Pharmaceuticals Ltd's Felodipine Extended-Release Tablets Under Fed Condition
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Objective:
Primary objective of the present study was to compare the single dose bioavailability of
Torrent's Felodipine Extended-Release Tablets USP 10 mg and Innovator's (Mylan
Pharmaceuticals Inc., USA) Felodipine Extended-Release Tablets USP 10 mg. Dosing periods were
separated by a washout period of 21 days during fasting study.
Study Design:
Open-Label, Randomised, two Period, two treatment, Crossover, Single-Dose Bioequivalence
Study